期刊文献+

动态灰阶超声造影在肝肿瘤诊断中的初步探索 被引量:2

Dynamic Grey Scale Enhanced Ultrasonography for Hepatic Tumors
下载PDF
导出
摘要 目的 探讨动态灰阶超声造影在肝肿瘤诊断中的初步表现和作用。方法 选择 6例经手术和病理证实的肝内实质性占位病变进行灰阶超声造影和动态观察。造影剂选用Levovist,浓度为 40 0mg/ml,以团注形式经肘部浅静脉注入。结果  6例病人证实为原发性肝癌 2例 ,肝血管瘤 2例 (3个 ) ,肝脏局灶性结节性增生 1例 ,肝脏炎性假瘤 1例。除肝脏炎性假瘤外 ,其余病灶经造影后均有不同程度的增强。肝癌早期呈不均匀强化 ,消失较快 ;肝血管瘤增强速度较慢 ,呈周边强化 ;肝脏局灶性结节性增生亦早期增强 ,但维持较长时间。结论 动态灰阶超声造影对提高肝肿瘤的诊断有其实际意义。 Objective To evaluate the value of dynamic grey scale enhanced ultrasound in the diagnosis of hepatic tumors. Methods Six patients with 7 hepatic tumors were examined by dynamic enhanced ultrasound with a bolus injection of Levovist (400mg/ml). Results Seven lesions were confirmed by pathology and operation. Of them, There were 2 hepatocellular carcinomas (HCC), 3 hepatic hemangiomas (HCH), 1 focal nodular hyperplasia (FNH) and 1 inflammatory pseudotumor of liver (IPL). Six hepatic lesions were variously enhanced on ultrasonogram by injecting Levovist except for one IPL. The lesions with HCCs were earlier enhanced in the arterial phase and earlier disappeared in portal phase. The lesions with HCHs were enhanced late in arterial phase and in the peripheral region of the lesion. The FNH were earlier enhanced in arterial phase and disappeared slowly in portal phase. Conclusion The dynamic grey scale enhanced ultrasound is useful in the diagnosis of hepatic tumors.
出处 《中国医学影像技术》 CSCD 2001年第12期1178-1179,共2页 Chinese Journal of Medical Imaging Technology
基金 上海市教委科研基金资助 (2 0 0 0QN0 9)
关键词 超声 灰阶 造影剂 肝肿瘤 诊断 Ultrasound Grey scale Contrast agent Hepatic tumor
  • 相关文献

参考文献6

  • 1[1]Srtobel D, Krudel U, Martus P, et al. Clinical evaluation of contrast enhanced color Doppler sonography in the differential diagnosis of liver tumors[J]. JCU, 2000,28(1): 1-13.
  • 2[2]Hosten N, Puls R, LemkeAJ, et al. Contrast enhanced power Doppler sonography: Improved detection of characteristic flow patterns in focal liver lesions[J]. J Clin Ultrasound, 1999,27(3):107-115.
  • 3[3]Gramiak R. Shah PM. Echocardiography of the aortic root[J].Invest Radiol, 1968,3(5): 356-366.
  • 4[4]MatsudaY, YabuuchiI. Hepatic tumors: US contrast enhancement with CO2 microbubbles[J]. Radiology, 1986,161(3): 701-705.
  • 5[5]Campani R, Bozzini A, Calliada F, et al. Color Doppler imaging of liver metastases. The value phase Ⅲ of a US contrast agent:SH U 508 A(Levovist) Schering[J]. Radiol Med(Torino),1994,87(5 Suppl 1):32-40.
  • 6[6]Numata K, Tanaka K, Kiba T, et al. Contrast enhanced,wide-band harmonic gray scale imaging of hepatocellular carcinoma: Correlation with helical computed tomographic findings[J]. J Ultrasound Med,2001,20(2):89-98.

同被引文献16

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部